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Background: COVID-19 pandemic has caused a worldwide situation of “missing patients” with acute 
myocardial infarction (AMI) suitable for a timely percutaneous coronary intervention (PCI).1 We aimed 
to investigate the impact of COVID-19 pandemic on PCI in AMI (ST elevation + non ST elevation MIs) 
in a hospital included in the national primary PCI network and dedicated for COVID-19 patients from 
Mar 2020. 
Patients and Methods: We compared numbers, characteristics and outcomes of patients presenting 
with AMI and receiving timely percutaneous intervention in our hospital between two periods: Jan 
2019 – Jan 2020 (“pre-COVID-19” era) and Mar 2020 – Dec 2020 (“COVID-19” era - 9 months period with 
mixed hospital organization: 4 months dedicated COVID-19 only hospital, and 5 months both non-
COVID-19 and COVID-19 hospital). 
Results: In the pre-COVID-19 era we performed 434 PCIs in 505 patients with AMI who received urgent/
early coronary angiography after admission (average monthly number of AMI suitable for revasculari-
zation: 42 patients), with in-hospital mortality of 3.7%. During the COVID-19 era there were 137 PCIs in 
186 patients with AMI and urgent/early coronary angiography (average monthly number of AMI suit-
able for revascularization: 18 patients), with in-hospital mortality of 8%. During the COVID-19 era, there 
were 14 COVID-19 positive patients with acute AMI who underwent urgent angiography (8 received PCI 
and 6 were treated conservatively) and had in-hospital mortality of 28%. 
Conclusion: We found an astonishing 40% reduction in monthly rates of patients with AMI suitable for 
revascularization presenting to our hospital during the COVID-19 pandemic. AMI patients that were 
treated with PCI during the pandemic era had significantly higher mortality, mostly influenced by a 
very high mortality rate of COVID-19 positive patients presenting with AMI. Comprehensive analysis 
of national primary PCI network organization and patient awareness of AMI during COVID-19 pan-
demic in Croatia is warranted. 
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